Influenza, immune system, and pregnancy

Reproductive Sciences

Volumn 21, Issue 12, 2014, Pages 1434-1451

  Raj, Renju S ^a   Bonney, Elizabeth A ^a   Phillippe, Mark ^b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

adaptive immunity; influenza; innate immunity; pregnancy

Indexed keywords

CHEMOKINE RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; ESTROGEN; GLUCOCORTICOID; PROGESTERONE; TOLL LIKE RECEPTOR; INFLUENZA VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; CELLULAR IMMUNITY; FETOPLACENTAL UNIT; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOTHERAPY; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; NATURAL KILLER CELL; NONHUMAN; PREGNANCY; RNA VIRUS; VACCINATION; VIROLOGY; VIRUS CELL INTERACTION; VIRUS RECOMBINANT; ANIMAL; DISEASE MODEL; FEMALE; HOST PATHOGEN INTERACTION; IMMUNIZATION; IMMUNOLOGY; INFLUENZA, HUMAN; INNATE IMMUNITY; MORTALITY; ORTHOMYXOVIRIDAE; PATHOGENICITY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS; RISK FACTOR;

ADAPTIVE IMMUNITY; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; IMMUNIZATION; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS; RISK FACTORS;

EID: 84911118345     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719114537720     Document Type: Article

References (215)

1. Palese PSM Fields Virology. Knipe DM HP, ed. Philadelphia: Lippincott, Williams & Wilkins ; 2007: 1647-1690.
2. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature. 2009 ; 459 ((7249)). 931-939
3. Taubenberger JK, Kash JC. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe. 2010 ; 7 ((6)). 440-451
4. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992 ; 56 ((1)). 152-179
5. Khiabanian H, Trifonov V, Rabadan R. Reassortment patterns in Swine influenza viruses. PLoS Curr. 2009 ; 1: RRN1008
6. Trifonov V, Khiabanian H, Greenbaum B, Rabadan R. The origin of the recent swine influenza A(H1N1) virus infecting humans. Euro Surveill. 2009 ; 14 ((17) ):
7. Watanabe T, Kawaoka Y. Pathogenesis of the 1918 pandemic influenza virus. PLoS Pathog. 2011 ; 7 ((1)). e1001218
8. Scholtissek C, Rohde W, Von Hoyningen V, Rott R. On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology. 1978 ; 87 ((1)). 13-20
9. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2008 ; 358 ((3)). 261-273
10. Gao R, Cao B, Hu Y, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013 ; 368 ((20)). 1888-1897
11. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine. 1999 ; 17 ((suppl 1)). S3 - S10
12. Wright PF NG, Kawaoka Y Fields Virology. Howley DMKaPM, ed. Philadelphia: Lippincott, Williams & Wilkins ; 2007: 1691-1740.
13. Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010 ; 303 ((15)). 1517-1525
14. Ellington SR, Hartman LK, Acosta M, et al. Pandemic 2009 influenza A (H1N1) in 71 critically ill pregnant women in California. Am J Obstet Gynecol. 2011 ; 204 ((6 suppl 1)). S21 - S30
15. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009 ; 374 ((9688)). 451-458
16. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010 ; 362 ((1)). 27-35
17. Woolston WJ, Conley DO. Epidemic pneumonia (spanish influenza) in pregnancy: effect in one hundred and one cases. J Am Med Assoc. 1918 ; 71 ((23)). 1898-1899
18. Bland PB. Influenza in its relation to pregnancy and labor. Am J Obstetr Dis Women Child. 1919 ; 79 (2). 184-197
19. Harris JW. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. J Am Med Assoc. 1919 ; 72 ((14)). 978-980
20. Hardy JM, Azarowicz EN, Mannini A, Medearis DN,, Cooke RE. The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957-1958. Am J Public Health Nations Health. 1961 ; 51: 1182-1188
21. Stanwell-Smith R, Parker AM, Chakraverty P, Soltanpoor N, Simpson CN. Possible association of influenza A with fetal loss: investigation of a cluster of spontaneous abortions and stillbirths. Commun Dis Rep CDR Rev. 1994 ; 4 ((3)). R28 - R32
22. Le Goffic R, Balloy V, Lagranderie M, et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2006 ; 2 ((6)). e53
23. Walsh JJ, Dietlein LF, Low FN, Burch GE, Mogabgab WJ. Bronchotracheal response in human influenza. Type A, Asian strain, as studied by light and electron microscopic examination of bronchoscopic biopsies. Arch Intern Med. 1961 ; 108: 376-388
24. Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest. 1959 ; 38 ((1 pt 2)). 213-265
25. O'Brien KL, Walters MI, Sellman J, et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis. 2000 ; 30 ((5)). 784-789
26. van der Sluijs KF, van Elden LJ, Nijhuis M, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol. 2004 ; 172 ((12)). 7603-7609
27. Brooks GF CK, Butel JS, Morse SA, Mietzner TA Jawetz, Melnick, & Adelberg's Medical Microbiology. 25 ed. Inc: The McGraw-Hill Companies ; 2010 :
28. Grossman JH DL The Human Placenta. JP L, ed. Maryland: Aspen Publishers ; 1987: 131-154.
29. Yawn DH, Pyeatte JC, Joseph JM, Eichler SL, Garcia-Bunuel R. Transplacental transfer of influenza virus. JAMA. 1971 ; 216 ((6)). 1022-1023
30. Jewett JF. Influenza pneumonia at term. N Engl J Med. 1974 ; 291 ((5)). 256-257
31. McGregor JA, Burns JC, Levin MJ, Burlington B, Meiklejohn G. Transplacental passage of influenza A/Bangkok (H3N2) mimicking amniotic fluid infection syndrome. Am J Obstet Gynecol. 1984 ; 149 ((8)). 856-859
32. Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet. 2007 ; 370 ((9593)). 1137-1145
33. Mel'nikova VF, Tsinzerling VA, Aksenov OA, Tsinzerling AV. [Chronic course of influenza with extrapulmonary involvement]. Arkh Patol. 1994 ; 56 ((1)). 33-38
34. Mel'nikova VF, Tsinzerling AV, Aksenov OA, Vydumkina SP, Kalinina NA. [Involvement of the afterbirth in influenza]. Arkh Patol. 1987 ; 49 ((9)). 19-25
35. Rosztoczy I, Sweet C, Toms GL, Smith H. Replication of influenza virus in organ cultures of human and simian urogenital tissues and human foetal tissues. Br J Exp Pathol. 1975 ; 56 ((4)). 322-328
36. Uchide N, Ohyama K, Bessho T, Toyoda H. Induction of pro-inflammatory cytokine gene expression and apoptosis in human chorion cells of fetal membranes by influenza virus infection: possible implications for maintenance and interruption of pregnancy during infection. Med Sci Monit. 2005 ; 11 ((1)). RA7 - R16
37. Uchide N, Ohyama K, Bessho T, Yuan B, Yamakawa T. Apoptosis in cultured human fetal membrane cells infected with influenza virus. Biol Pharm Bull. 2002 ; 25 ((1)). 109-114
38. Uchide N, Ohyama K, Yuan B, Bessho T, Yamakawa T. Differentiation of monocytes to macrophages induced by influenza virus-infected apoptotic cells. J Gen Virol. 2002 ; 83 ((pt 4)). 747-751
39. Uchide N, Tadera C, Sarai H, Ohyama K, Bessho T, Toyoda H. Characterization of monocyte differentiation-inducing (MDI) factors derived from human fetal membrane chorion cells undergoing apoptosis after influenza virus infection. Int J Biochem Cell Biol. 2006 ; 38 ((11)). 1926-1938
40. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science. 2010 ; 327 ((5963)). 291-295
41. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006 ; 7 ((2)). 131-137
42. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004 ; 5 ((10)). 987-995
43. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol. 2005 ; 23: 307-336
44. Sato A, Iwasaki A. Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments. Proc Natl Acad Sci U S A. 2004 ; 101 ((46)). 16274-16279
45. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998 ; 392 ((6673)). 245-252
46. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001 ; 2 ((8)). 675-680
47. Janeway CA,, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002 ; 20: 197-216
48. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010 ; 11 ((5)). 373-384
49. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006 ; 124 ((4)). 783-801
50. Guillot L, Le Goffic R, Bloch S, et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem. 2005 ; 280 ((7)). 5571-5580
51. Perussia B, Fanning V, Trinchieri G. A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat Immu Cell Growth Regul. 1985 ; 4 ((3)). 120-137
52. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004 ; 4 ((7)). 499-511
53. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996 ; 87 ((6)). 2095-2147
54. Adachi O, Kawai T, Takeda K, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 1998 ; 9 ((1)). 143-150
55. Seo SU, Kwon HJ, Song JH, et al. MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection. J Virol. 2010 ; 84 ((24)). 12713-12722
56. Lund JM, Alexopoulou L, Sato A, et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A. 2004 ; 101 ((15)). 5598-5603
57. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature. 2008 ; 452 ((7184)). 234-238
58. Tabeta K, Hoebe K, Janssen EM, et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol. 2006 ; 7 ((2)). 156-164
59. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004 ; 303 ((5663)). 1529-1531
60. Garcia-Sastre A. Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. Microbes Infect. 2002 ; 4 ((6)). 647-655
61. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40 L drive a potent TH1 polarization. Nat Immunol. 2000 ; 1 ((4)). 305-310
62. Asselin-Paturel C, Boonstra A, Dalod M, et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol. 2001 ; 2 ((12)). 1144-1150
63. Diebold SS, Montoya M, Unger H, et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature. 2003 ; 424 ((6946)). 324-328
64. Koga K, Mor G. Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol. 2010 ; 63 ((6)). 587-600
65. Beijar EC, Mallard C, Powell TL. Expression and subcellular localization of TLR-4 in term and first trimester human placenta. Placenta. 2006 ; 27 ((2-3)). 322-326
66. Mitsunari M, Yoshida S, Shoji T, et al. Macrophage-activating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E(2) via toll-like receptor 2 in human placental trophoblast cells. J Reprod Immunol. 2006 ; 72 ((1-2)). 46-59
67. Abrahams VM, Bole-Aldo P, Kim YM, et al. Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol. 2004 ; 173 ((7)). 4286-4296
68. Tinsley JH, Chiasson VL, Mahajan A, Young KJ, Mitchell BM. Toll-like receptor 3 activation during pregnancy elicits preeclampsia-like symptoms in rats. Am J Hypertens. 2009 ; 22 ((12)). 1314-1319
69. Panda B, Panda A, Ueda I, et al. Dendritic cells in the circulation of women with preeclampsia demonstrate a pro-inflammatory bias secondary to dysregulation of TLR receptors. J Reprod Immunol. 2012 ; 94 ((2)). 210-215
70. Thaxton JE, Romero R, Sharma S. TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol. 2009 ; 183 ((2)). 1144-1154
71. Ilievski V, Lu SJ, Hirsch E. Activation of toll-like receptors 2 or 3 and preterm delivery in the mouse. Reprod Sci. 2007 ; 14 ((4)). 315-320
72. Nitsche JF, Jiang SW, Brost BC. Toll-like receptor-2 and toll-like receptor-4 expression on maternal neutrophils during pregnancy. Am J Reprod Immunol. 2010 ; 64 ((6)). 427-434
73. Vanders RL, Gibson PG, Murphy VE, Wark PA. Plasmacytoid dendritic cells and CD8 T cells from pregnant women show altered phenotype and function following H1N1/09 infection. J Infect Dis. 2013 ; 208 ((7)). 1062-1070
74. Young BC, Stanic AK, Panda B, Rueda BR, Panda A. Longitudinal expression of Toll-like receptors on dendritic cells in uncomplicated pregnancy and postpartum. Am J Obstet Gynecol. 2014 ; 210 ((5)). e1 - e6
75. Conn CA, McClellan JL, Maassab HF, Smitka CW, Majde JA, Kluger MJ. Cytokines and the acute phase response to influenza virus in mice. Am J Physiol. 1995 ; 268 ((1 pt 2)). R78 - R84
76. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003 ; 21: 335-376
77. Choudhary S, Gao J, Leaman DW, De BP. Interferon action against human parainfluenza virus type 3: involvement of a novel antiviral pathway in the inhibition of transcription. J Virol. 2001 ; 75 ((10)). 4823-4831
78. Khaitov MR, Laza-Stanca V, Edwards MR, et al. Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allergy. 2009 ; 64 ((3)). 375-386
79. Honda K, Yanai H, Takaoka A, Taniguchi T. Regulation of the type I IFN induction: a current view. Int Immunol. 2005 ; 17 ((11)). 1367-1378
80. Forbes RL, Wark PA, Murphy VE, Gibson PG. Pregnant women have attenuated innate interferon responses to 2009 pandemic influenza A virus subtype H1N1. J Infect Dis. 2012 ; 206 ((5)). 646-653
81. Plata-Salaman CR. Immunoregulators in the nervous system. Neurosci Biobehav Rev. 1991 ; 15 ((2)). 185-215
82. Tracey KJ, Cerami A. Tumor necrosis factor: an updated review of its biology. Crit Care Med. 1993 ; 21 ((10 suppl)). S415 - S422
83. Peper RL, Van Campen H. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb Pathog. 1995 ; 19 ((3)). 175-183
84. Heltzer ML, Coffin SE, Maurer K, et al. Immune dysregulation in severe influenza. J Leukoc Biol. 2009 ; 85 ((6)). 1036-1043
85. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008 ; 9 ((5)). 503-510
86. Denney L, Aitken C, Li CK, et al. Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection. PLoS One. 2010 ; 5 ((5)). e10675
87. Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol Rev. 1997 ; 159: 95-103
88. Virelizier JL. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol. 1975 ; 115 ((2)). 434-439
89. Schulman JL, Kilbourne ED. Induction of Partial Specific Heterotypic Immunity in Mice by a Single Infection with Influenza a Virus. J Bacteriol. 1965 ; 89: 170-174
90. McKinstry KK, Strutt TM, Swain SL. Hallmarks of CD4 T cell immunity against influenza. J Intern Med. 2011 ; 269 ((5)). 507-518
91. Mathews JD, McBryde ES, McVernon J, Pallaghy PK, McCaw JM. Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918-9. BMC Infect Dis. 2010 ; 10: 128
92. Scheible K, Zhang G, Baer J, et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine. 2011 ; 29 ((11)). 2159-2168
93. Gordon CL, Johnson PD, Permezel M, et al. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis. 2010 ; 50 ((5)). 672-678
94. Zheng R, Qin X, Li Y, et al. Imbalanced anti-H1N1 immunoglobulin subclasses and dysregulated cytokines in hospitalized pregnant women with 2009 H1N1 influenza and pneumonia in Shenyang, China. Hum Immunol. 2012 ; 73 ((9)). 906-911
95. Parry S, Strauss JF. Premature rupture of the fetal membranes. N Engl J Med. 1998 ; 338 ((10)). 663-670
96. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy - an inflammatory view. Trends Immunol. 2006 ; 27 ((9)). 399-404
97. Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM. Inflammatory processes in preterm and term parturition. J Reprod Immunol. 2008 ; 79 ((1)). 50-57
98. Smarason AK, Gunnarsson A, Alfredsson JH, Valdimarsson H. Monocytosis and monocytic infiltration of decidua in early pregnancy. J Clin Lab Immunol. 1986 ; 21 ((1)). 1-5
99. Kraus TA, Sperling RS, Engel SM, et al. Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol. 2010 ; 64 ((6)). 411-426
100. Khakpour M, Saidi A, Naficy K. Proved viraemia in Asian influenza (Hong Kong variant) during incubation period. Br Med J. 1969 ; 4 ((5677)). 208-209
101. Naficy K.. Human influenza infection with proved viremia. Report of a case. N Engl J Med. 1963 ; 269: 964-966
102. Uchide N, Ohyama K, Yuan B, Sano T, Bessho T, Yamakawa T. Differential mRNA expression of inflammatory cytokines in cultured human fetal membrane cells responding to influenza virus infection. Biol Pharm Bull. 2002 ; 25 ((2)). 239-243
103. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980 ; 68: 251-306
104. Uchide N, Ohyama K. Antiviral function of pyrrolidine dithiocarbamate against influenza virus: the inhibition of viral gene replication and transcription. J Antimicrob Chemother. 2003 ; 52 ((1)). 8-10
105. Uchide N, Ohyama K, Bessho T, Yuan B, Yamakawa T. Effect of antioxidants on apoptosis induced by influenza virus infection: inhibition of viral gene replication and transcription with pyrrolidine dithiocarbamate. Antiviral Res. 2002 ; 56 ((3)). 207-217
106. Uchide N, Suzuki A, Ohyama K, Bessho T, Toyoda H. Secretion of bioactive interleukin-6 and tumor necrosis factor-alpha proteins from primary cultured human fetal membrane chorion cells infected with influenza virus. Placenta. 2006 ; 27 ((6-7)). 678-690
107. Park JB. Phagocytosis induces superoxide formation and apoptosis in macrophages. Exp Mol Med. 2003 ; 35 ((5)). 325-335
108. Lappas M, Permezel M, Georgiou HM, Rice GE. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. J Clin Endocrinol Metab. 2002 ; 87 ((10)). 4667-4672
109. Sullivan MH, Alvi SA, Brown NL, Elder MG, Bennett PR. The effects of a cytokine suppressive anti-inflammatory drug on the output of prostaglandin E(2) and interleukin-1 beta from human fetal membranes. Mol Hum Reprod. 2002 ; 8 ((3)). 281-285
110. Lappas M, Permezel M, Georgiou HM, Rice GE. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod. 2002 ; 67 ((2)). 668-673
111. Denison FC, Kelly RW, Calder AA, Riley SC. Cytokine secretion by human fetal membranes, decidua and placenta at term. Hum Reprod. 1998 ; 13 ((12)). 3560-3565
112. Uchide N, Ohyama K, Bessho T, Takeichi M, Toyoda H. Possible roles of proinflammatory and chemoattractive cytokines produced by human fetal membrane cells in the pathology of adverse pregnancy outcomes associated with influenza virus infection. Mediators Inflamm. 2012 ; 270670: 2012
113. Marvin KW, Keelan JA, Eykholt RL, Sato TA, Mitchell MD. Use of cDNA arrays to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm. Mol Hum Reprod. 2002 ; 8 ((4)). 399-408
114. Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000 ; 96 ((5)). 1723-1732
115. Tsatsanis C, Margioris AN, Kontoyiannis DP. Association between H1N1 infection severity and obesity-adiponectin as a potential etiologic factor. J Infect Dis. 2010 ; 202 ((3)). 459-460
116. Avitsur R, Hunzeker J, Sheridan JF. Role of early stress in the individual differences in host response to viral infection. Brain Behav Immun. 2006 ; 20 ((4)). 339-348
117. Avitsur R, Kavelaars A, Heijnen C, Sheridan JF. Social stress and the regulation of tumor necrosis factor-alpha secretion. Brain Behav Immun. 2005 ; 19 ((4)). 311-317
118. Johnson JD, O'Connor KA, Deak T, Stark M, Watkins LR, Maier SF. Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav Immun. 2002 ; 16 ((4)). 461-476
119. Christian LM, Franco A, Iams JD, Sheridan J, Glaser R. Depressive symptoms predict exaggerated inflammatory responses to an in vivo immune challenge among pregnant women. Brain Behav Immun. 2010 ; 24 ((1)). 49-53
120. Thangavel RR, Bouvier NM J Immunol Methods. 2014 :
121. Moncla LH, Ross TM, Dinis JM, et al. A novel nonhuman primate model for influenza transmission. PLoS One. 2013 ; 8 ((11)). e78750
122. Bouvier NM, Lowen AC. Animal models for influenza virus pathogenesis and transmission. Viruses. 2010 ; 2 ((8)). 1530-1563
123. Eichelberger MC, Green MD. Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines. Expert Opinion Drug Metabol Toxicol. 2011 ; 7 ((9)). 1117-1127
124. Tripp RA, Tompkins SM. Animal models for evaluation of influenza vaccines. Curr Top Microbiol Immunol. 2009 ; 333: 397-412
125. Barnard DL. Animal models for the study of influenza pathogenesis and therapy. Antiviral Res. 2009 ; 82 ((2)). A110 - A122
126. Kash JC, Basler CF, Garcia-Sastre A, et al. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J Virol. 2004 ; 78 ((17)). 9499-9511
127. Kobasa D, Takada A, Shinya K, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature. 2004 ; 431 ((7009)). 703-707
128. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci U S A. 2004 ; 101 ((9)). 3166-3171
129. Kash JC, Tumpey TM, Proll SC, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature. 2006 ; 443 ((7111)). 578-581
130. Tumpey TM, Garcia-Sastre A, Taubenberger JK, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol. 2005 ; 79 ((23)). 14933-14944
131. Kobasa D, Jones SM, Shinya K, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature. 2007 ; 445 ((7125)). 319-323
132. Cheung CY, Poon LL, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet. 2002 ; 360 ((9348)). 1831-1837
133. Lee DC, Cheung CY, Law AH, Mok CK, Peiris M. Lau AS. p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J Virol. 2005 ; 79 ((16)). 10147-10154
134. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respiratory research. 2005 ; 6: 135
135. Xu T, Qiao J, Zhao L, et al. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Crit Care Med. 2006 ; 174 ((9)). 1011-1017
136. de Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 2005 ; 352 ((7)). 686-691
137. Szretter KJ, Gangappa S, Lu X, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol. 2007 ; 81 ((6)). 2736-2744
138. Hui KP, Lee SM, Cheung CY, et al. Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. J Immunol. 2009 ; 182 ((2)). 1088-1098
139. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A. 2007 ; 104 ((30)). 12479-12481
140. Luo H, Wang D, Che HL, Zhao Y, Jin H. Pathological observations of lung inflammation after administration of IP-10 in influenza virus- and respiratory syncytial virus-infected mice. Exp Ther Med. 2012 ; 3 ((1)). 76-79
141. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol. 2000 ; 156 ((6)). 1951-1959
142. Cook DN, Beck MA, Coffman TM, et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science. 1995 ; 269 ((5230)). 1583-1585
143. Tedla N, Wang HW, McNeil HP, et al. Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta. J Immunol. 1998 ; 161 ((10)). 5663-5672
144. Opal SM, Wherry JC, Grint P. Interleukin-10: potential benefits and possible risks in clinical infectious diseases. Clin Infect Dis. 1998 ; 27 ((6)). 1497-1507
145. Strutt TM, McKinstry KK, Dibble JP, et al. Memory CD4+ T cells induce innate responses independently of pathogen. Nat Med. 2010 ; 16 ((5)). 558-564
146. Kreijtz JH, Bodewes R, van Amerongen G, et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine. 2007 ; 25 ((4)). 612-620
147. Hikono H, Kohlmeier JE, Ely KH, et al. T-cell memory and recall responses to respiratory virus infections. Immunol Rev. 2006 ; 211: 119-132
148. Woodland DL, Scott I. T cell memory in the lung airways. Proc Am Thorac Soc. 2005 ; 2 ((2)). 126-131
149. Seo SH, Peiris M, Webster RG. Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-like H5N1 influenza virus is correlated with the proportion of pulmonary CD8(+) T cells expressing gamma interferon. J Virol. 2002 ; 76 ((10)). 4886-4890
150. Deliyannis G, Jackson DC, Ede NJ, et al. Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus. J Virol. 2002 ; 76 ((9)). 4212-4221
151. Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC. Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol. 2002 ; 76 ((23)). 12388-12393
152. Dienz O, Eaton SM, Bond JP, et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J Exp Med. 2009 ; 206 ((1)). 69-78
153. Hufford MM, Kim TS, Sun J, Braciale TJ. Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J Exp Med. 2011 ; 208 ((1)). 167-180
154. Wiley JA, Cerwenka A, Harkema JR, Dutton RW, Harmsen AG. Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. Am J Pathol. 2001 ; 158 ((1)). 119-130
155. Moskophidis D, Kioussis D. Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med. 1998 ; 188 ((2)). 223-232
156. Pazos MA, Kraus TA, Munoz-Fontela C, Moran TM. Estrogen mediates innate and adaptive immune alterations to influenza infection in pregnant mice. PLoS One. 2012 ; 7 ((7)). e40502
157. Scalzo AA, Anders EM. Influenza viruses as lymphocyte mitogens. I. B cell mitogenesis by influenza A viruses of the H2 and H6 subtypes is controlled by the I-E/C subregion of the major histocompatibility complex. J Immunol. 1985 ; 134 ((2)). 757-760
158. Marshall-Clarke S, Tasker L, Buchatska O, et al. Influenza H2 haemagglutinin activates B cells via a MyD88-dependent pathway. Eur J Immunol. 2006 ; 36 ((1)). 95-106
159. Williams K, Mackenzie JS. Influenza infections during pregnancy in the mouse. J Hyg (Lond). 1977 ; 79 ((2)). 249-257
160. Mackenzie JS, Williams K, Papadimitriou J. Influenza A virus and its influence on the outcome of pregnancy in the mouse. Dev Biol Stand. 1977 ; 39: 489-496
161. Chan KH, Zhang AJ, To KK, et al. Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice. PLoS One. 2010 ; 5 ((10)). e13757
162. Kim HM, Kang YM, Song BM, Kim HS, Seo SH. The 2009 pandemic H1N1 influenza virus is more pathogenic in pregnant mice than seasonal H1N1 influenza virus. Viral Immunol. 2012 ; 25 ((5)). 402-410
163. Marcelin G, Aldridge JR, Duan S, et al. Fatal Outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice. J Virol. 2011 ; 85 ((21)). 11208-11219
164. Gonzalez JM, Ofori E, Burd I, Chai J, Scholler N, Elovitz MA. Maternal mortality from systemic illness: unraveling the contribution of the immune response. Am J Obstet Gynecol. 2009 ; 200 ((4)). e431-438
165. Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav. 2012 ; 62 ((3)). 263-271
166. Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol. 1996 ; 156 ((2)). 644-652
167. Luft BJ, Remington JS. Effect of pregnancy on resistance to Listeria monocytogenes and Toxoplasma gondii infections in mice. Infect Immun. 1982 ; 38 ((3)). 1164-1171
168. Szekeres-Bartho J, Polgar B. PIBF: the double edged sword. Pregnancy and tumor. Am J Reprod Immunol. 2010 ; 64 ((2)). 77-86
169. Szekeres-Bartho J, Wegmann TG. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol. 1996 ; 31 ((1-2)). 81-95
170. Szekeres-Bartho J, Faust Z, Varga P, Szereday L, Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol. 1996 ; 35 ((4)). 348-351
171. Veenstra van Nieuwenhoven AL, Bouman A, Moes H, et al. Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle. Fertil Steril. 2002 ; 77 ((5)). 1032-1037
172. Sacks GP, Clover LM, Bainbridge DR, Redman CW, Sargent IL. Flow cytometric measurement of intracellular Th1 and Th2 cytokine production by human villous and extravillous cytotrophoblast. Placenta. 2001 ; 22 ((6)). 550-559
173. Ostensen M. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ann N Y Acad Sci. 1999 ; 876: 131-143
174. Marzi M, Vigano A, Trabattoni D, et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol. 1996 ; 106 ((1)). 127-133
175. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol. 1993 ; 151 ((9)). 4562-4573
176. Alijotas-Reig J, Llurba E, Gris JM. Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells. Placenta. 2014 ; 35 ((4)). 241-248
177. Zenclussen AC, Gerlof K, Zenclussen ML, et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol. 2005 ; 166 ((3)). 811-822
178. Zenclussen AC, Fest S, Busse P, Joachim R, Klapp BF, Arck PC. Questioning the Th1/Th2 paradigm in reproduction: peripheral levels of IL-12 are down-regulated in miscarriage patients. Am J Reprod Immunol. 2002 ; 48 ((4)). 245-251
179. Robinson DP, Lorenzo ME, Jian W, Klein SL. Elevated 17beta-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses. PLoS Pathog. 2011 ; 7 ((7)). e1002149
180. Greenlee MM, Mitzelfelt JD, Yu L, et al. Estradiol activates epithelial sodium channels in rat alveolar cells through the G protein-coupled estrogen receptor. Am J Physiol Lung Cell Mol Physiol. 2013 ; 305 ((11)). L878 - L889
181. Gu X, Li P, Liu H, Li N, Li S, Sakuma T. The effect of influenza virus A on th1/th2 balance and alveolar fluid clearance in pregnant rats. Exp Lung Res. 2011 ; 37 ((7)). 445-451
182. Chen XJ, Seth S, Yue G, et al. Influenza virus inhibits ENaC and lung fluid clearance. Am J Physiol Lung Cell Mol Physiol. 2004 ; 287 ((2)). L366 - L373
183. Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull. 2006 ; 32 ((2)). 200-202
184. Gilmore JH, Fredrik Jarskog L, Vadlamudi S, Lauder JM. Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development. Neuropsychopharmacology. 2004 ; 29 ((7)). 1221-1229
185. Mednick SA, Machon RA, Huttunen MO, Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry. 1988 ; 45 ((2)). 189-192
186. Meyer U, Feldon J, Schedlowski M, Yee BK. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev. 2005 ; 29 ((6)). 913-947
187. Short SJ, Lubach GR, Karasin AI, et al. Maternal influenza infection during pregnancy impacts postnatal brain development in the rhesus monkey. Biol Psychiatry. 2010 ; 67 ((10)). 965-973
188. Parboosing R, Bao Y, Shen L, Schaefer CA, Brown AS. Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry (Chicago, Ill.). 2013 ; 70 ((7)). 677-685
189. Toth LA. Strain differences in the somnogenic effects of interferon inducers in mice. J Interferon Cytokine Res. 1996 ; 16 ((12)). 1065-1072
190. Cox RJ, Brokstad KA, Ogra P. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol. 2004 ; 59 ((1)). 1-15
191. Gross PA, Ennis FA, Gaerlan PF, Denson LJ, Denning CR, Schiffman D. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J Infect Dis. 1977 ; 136 ((5)). 623-632
192. Barry DW, Mayner RE, Staton E, et al. Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man. Am J Epidemiol. 1976 ; 104 ((1)). 34-46
193. Hovden AO, Cox RJ, Madhun A, Haaheim LR. Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice. Scand J Immunol. 2005 ; 62 ((4)). 342-352
194. ACOG committee opinion no. 558: Integrating immunizations into practice. Obstet Gynecol. 2013 ; 121 ((4)). 897-903
195. Recommendations of the Advisory Committee on Immunization Practices - United States, 2013-2014. MMWR Recomm Rep. 2013 ; 62 ((RR-07)). 1-43
196. Bednarczyk RA, Adjaye-Gbewonyo D, Omer SB. Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol. 2012 ; 207 ((3)). S38 - S46
197. Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006 ; 55 ((RR-10)). 1-42
198. Nordin JD, Kharbanda EO, Vazquez Benitez G, et al. Maternal influenza vaccine and risks for preterm or small for gestational age birth. J Pediatr. 2014 ; 164 ((5)). 1051-1057.e2
199. Legge A, Dodds L, Macdonald NE, Scott J, McNeil S. Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. CMAJ. 2014 ; 186 ((4)). E157 - E164
200. Chambers CD, Johnson D, Xu R, et al. Risks and safety of pandemic h1n1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine. 2013 ; 31 ((44)). 5026-5032
201. Moro PL, Museru OI, Broder K, et al. Safety of influenza A (H1N1) 2009 live attenuated monovalent vaccine in pregnant women. Obstet Gynecol. 2013 ; 122 ((6)). 1271-1278
202. Kennedy ED, Ahluwalia IB, Ding H, Lu P-J, Singleton JA, Bridges CB. Monitoring seasonal influenza vaccination coverage among pregnant women in the United States. Am J Obstet Gynecol. 2012 ; 207 ((3 suppl)). S9 - S16
203. Rasmussen SA, Watson AK, Kennedy ED, Broder KR, Jamieson DJ. Vaccines and pregnancy: past, present, and future [published online December 16, 2013]. Semin Fetal Neonatal Medicine. Dec. 2013 ;: 16
204. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008 ; 359 ((15)). 1555-1564
205. Steinhoff MC, Omer SB, Roy E, et al. Influenza immunization in pregnancy - antibody responses in mothers and infants. N Engl J Med. 2010 ; 362 ((17)). 1644-1646
206. Yamaguchi K, Hisano M, Isojima S, et al. Relationship of Th1/Th2 cell balance with the immune response to influenza vaccine during pregnancy. J Med Virol. 2009 ; 81 ((11)). 1923-1928
207. Hwang SD, Shin JS, Ku KB, Kim HS, Cho SW, Seo SH. Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination. Vaccine. 2010 ; 28 ((17)). 2957-2964
208. Luke TC, Kilbane EM, Jackson JL, Hoffman SL. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?. Ann Intern Med. 2006 ; 145 ((8)). 599-609
209. Hammerbeck DM, Burleson GR, Schuller CJ, et al. Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats. Antiviral Res. 2007 ; 73 ((1)). 1-11
210. Wong JP, Saravolac EG, Sabuda D, Levy HB, Kende M. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice. Antimicrob Agents Chemother. 1995 ; 39 ((11)). 2574-2576
211. McFarlin DE, Bever CT, Salazar AM, Levy HB. A preliminary trial of poly(I, C)-LC in multiple sclerosis. J Biol Response Mod. 1985 ; 4 ((5)). 544-548
212. Koga K, Cardenas I, Aldo P, et al. Activation of TLR3 in the trophoblast is associated with preterm delivery. Am J Reprod Immunol. 2009 ; 61 ((3)). 196-212
213. Liu Y, Li S, Zhang G, et al. Genetic variants in IL1A and IL1B contribute to the susceptibility to 2009 pandemic H1N1 influenza A virus. BMC Immunol. 2013 ; 14: 37
214. Juno J, Fowke KR, Keynan Y. Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses. Clin Dev Immunol. 2012 ; 797180: 2012
215. Kumar PA, Hu Y, Yamamoto Y, et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell. 2011 ; 147 ((3)). 525-538